When the CPS cutoff value was set at 5, three controls (7.9%), 11 patients with colorectal adenomas (20%), and 67 patients with CRC (48.6%) were positive for PD-L1 expression (S1 Table). This evidence concerns the gene CD274 and colorectal carcinoma.